Using injectables in this way has not been researched, so the safety has not been established
[6] Amplified NOS Activity - Glutathione stimulates total L-arginine turnover and increases NOS activity, resulting in greater NO production from available L-arginine
It is not known if compounded tirzepatide can be used in people who have had pancreatitis
[3] Individuals with obesity may be candidates for tirzepatide (Zepbound), which is FDA-approved for chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
In addition to decreasing food intake, GLP-1 has also been shown to decrease drug intake, self-administration, conditioned place preference, and seeking in animal models (Eren-Yazicioglu et al., 2021), suggesting that GLP-1 can decrease reward responses for food rewards and beyond